H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents(CTSO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-08 AccNo: 0000215457-19-006839 Size: 13 KB 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-02-05 AccNo: 0001144204-19-005023 Size: 52 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-01-24 AccNo: 0001144204-19-002623 Size: 54 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001144204-19-000926 Size: 70 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-11-07 AccNo: 0001144204-18-058036 Size: 155 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-06 AccNo: 0001144204-18-057624 Size: 7 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 美东时间 2018-11-06 盘后 披露财报,预期EPS -0.13 网页链接
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-09-05,总裁 and CEO,Chan Phillip P. ,卖出,5787普通股, $14.85
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-09-06,总裁 and CEO,Chan Phillip P. ,卖出,2900普通股, $14.75
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-09-07,总裁 and CEO,Chan Phillip P. ,卖出,2731普通股, $14.11